VS

Venkata Subba Reddy Vemireddy

Active Director Director DIN 02147341
DIN 02147341 First appointment May 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since May 2008
Shareholding value •••• Premium profile

About Venkata Subba Reddy Vemireddy

Data last updated:

Venkata Subba Reddy Vemireddy is a Director at Sada Pharma Private Limited (since 2019), Director at Vj Fine Chem Private Limited (since 2017) and Director at Vj Life Sciences Private Limited (since 2023). The companies operate in Pharma, Wood and Chemicals and Materials. The 2 current companies with reported revenue have a combined latest revenue of ₹9.11 Cr; the largest is Sada Pharma Private Limited at ₹8.90 Cr (FY 2025). Earlier, Venkata Subba Reddy Vemireddy was a Director at Venus Chemicals And Drugs Private Limited (2015–2016) and Director at Kevy's Generics Private Limited (2008–2013).

DIN 02147341
Primary Designation Director
Industry Pharma
First Appointment 14 May 2008
Oldest Company Age 19 yrs
Largest company Sada Pharma Private Limited · ₹8.90 Cr (FY 2025)
Combined revenue ₹9.11 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sada Pharma Private Limited U24233TG2007PTC054755
Director18 Sep 20192007₹8.90 Cr (FY 2025)Active
Vj Fine Chem Private Limited U24304TG2017PTC114584
Director06 Feb 20172017₹21.1 Lakh (FY 2023)Active
Vj Life Sciences Private Limited U20119TS2023PTC175935
Director10 Aug 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Dec 20152013₹59.13 Cr (FY 2025)Active
Kevy's Generics Private Limited U24233TG2008PTC059172
Director14 May 20082008₹26.72 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sada Pharma Private Limited
Vj Fine Chem Private Limited
Vj Life Sciences Private Limited
Venus Chemicals And Drugs Private Limited
Premium access

Shareholding and investment profile for Venkata Subba Reddy Vemireddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Subba Reddy Vemireddy

Venkata Subba Reddy Vemireddy currently holds 3 directorships: Sada Pharma Private Limited (Director, since 18 Sep 2019, revenue ₹8.90 Cr (FY 2025)); Vj Fine Chem Private Limited (Director, since 06 Feb 2017, revenue ₹21.1 Lakh (FY 2023)); Vj Life Sciences Private Limited (Director, since 10 Aug 2023).

Venkata Subba Reddy Vemireddy was first appointed on 14 May 2008 as Director at Kevy's Generics Private Limited. The most recent appointment on record is 10 Aug 2023 at Vj Life Sciences Private Limited.

The 2 current companies of Venkata Subba Reddy Vemireddy that report revenue have a combined latest revenue of ₹9.11 Cr: Sada Pharma Private Limited ₹8.90 Cr (FY 2025); Vj Fine Chem Private Limited ₹21.1 Lakh (FY 2023).

Venkata Subba Reddy Vemireddy held 2 earlier board appointments: Venus Chemicals And Drugs Private Limited (Director, 01 Dec 2015 to 29 Apr 2016); Kevy's Generics Private Limited (Director, 14 May 2008 to 04 Apr 2013).

The current boards of Venkata Subba Reddy Vemireddy's companies include Jaya Prakash Goli (Sada Pharma Private Limited), Shyam Sunder Reddy (Sada Pharma Private Limited), Sivaramakrishna Reddy Alla (Sada Pharma Private Limited), Tirumalesh Tiruveedi (Vj Fine Chem Private Limited), Srinivas Madduri (Vj Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available